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To determine the immediate effects of bilevel non-invasive ventilation plus oxygen (NIVþO2)
during exercise compared to exercise with O2 alone in people recovering from acute on chronic
hypercapnic respiratory failure (HRF), a randomised crossover study with repeated measures
was performed.
Eighteen participants performed six minute walk tests (6MWT) and 16 participants
performed unsupported arm exercise (UAE) tests with NIVþO2 and with O2 alone in random
order.
Distance walked increased by a mean of 43.4 m (95% CI 14.1 to 72.8, pZ 0.006) with
NIVþO2 compared to exercise with O2 alone. In addition, isotime oxygen saturation increased
by a mean of 5% (95% CI 2e7, pZ 0.001) and isotime dyspnoea was reduced [median 2 (inter-
quartile range (IQR) 1e4) versus 4 (3e5), pZ 0.028] with NIVþO2. A statistically significant
increase was also observed in UAE endurance time with NIVþ O2 [median 201 s (IQR 93e414)
versus 157 (90e342), pZ 0.033], and isotime perceived exertion (arm muscle fatigue) was
reduced by a mean of 1.0 on the Borg scale (95% CI 1.9 to 0.1, pZ 0.037) compared with
O2 alone.
Non-invasive ventilation plus O2 during walking resulted in an immediate improvement in
distance walked and oxygen saturation, and a reduction in dyspnoea compared to exercise
with O2 alone in people recovering from acute on chronic HRF. The reduction of dyspnoea
during walking and arm muscle fatigue during UAE observed with NIVþO2 may allow patients
to better tolerate exercise early in the recovery period.
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Patients with chronic hypercapnic respiratory failure (HRF)
have a decreased exercise capacity and reduced activity
levels compared to healthy controls.1,2 They often report
severe exertional dyspnoea3 and have limited ventilatory
reserve during exercise.4,5 With the development of acute
on chronic HRF, ventilatory capacity decreases further.6,7
Consequently, severe dyspnoea8 and unstable gas exchange
may delay the onset of exercise rehabilitation and place
patients at risk of further deconditioning.
Non-invasive ventilation during exercise has been shown
to reduce dyspnoea in proportion to respiratory muscle
unloading,9,10 improve gas exchange,11e13 and increase
endurance time compared to unassisted exercise in
patients with chronic HRF secondary to severe COPD3,11 and
severe restrictive chest wall disorders.14e16 While invasive
mechanical ventilation during walking has been described
in stable hospitalised ventilator-dependent patients8,17,18
and during supported arm exercise (SAE) in difficult to wean
patients with COPD and HRF,19 the effect of non-invasive
ventilation plus oxygen (NIVþO2) during walking or during
functional (unsupported) arm exercise compared to stan-
dard therapy (exercise with O2 alone) is unknown in
patients recovering from acute on chronic HRF. If NIVþO2
during exercise can provide similar benefits to patients
recovering from acute HRF as in stable patients with HRF,
it may permit exercise rehabilitation to be commenced
earlier in the hospital stay, thus reducing the risk of further
deconditioning.
The aim of the present study was to determine the
effects of bilevel NIVþO2 during ground walking and
unsupported arm exercise (UAE) on exercise capacity
compared to exercise with O2 alone in people recovering
from acute on chronic HRF. We hypothesised that NIVþO2
during exercise would reduce dyspnoea, improve oxygena-
tion and allow patients to exercise for longer compared
with O2 alone.Method
Participants
Fourteen participants recovering from acute on chronic HRF
performed a series of six minute walk tests (6MWT) and
a series of UAE tests. An additional four participants
performed the 6MWT only, giving a total of 18 participants
who performed the series of 6MWT. An additional two
participants performed UAE tests only, giving a total of
16 participants who performed the series of UAE tests.
Participant characteristics are described in Table 1. Inclusion
criteria were all of the following: admitted to hospital
with acute on chronic HRF (pH< 7.35, PaCO2> 45 mmHg,
HCO3
> 26 mmol/L) that required ongoing treatment with
NIV; history of severe chronic lung disease or severe chestwall
restrictive disorder; dyspnoea as the primary symptom that
limited daily activities. Bilevel NIV was commenced if the
respiratory acidosis (pH< 7.35) persisted despite judicious
use of supplemental O2 therapy. Standard medical therapy
was instituted in conjunction with NIV and included, but was
not limited to, supplemental O2, bronchodilators, antibiotics,
corticosteroids and diuretics where indicated. Exclusioncriteria at the time of exercise testing were any of the
following: unable to tolerate>1 h off NIV; arterial pH< 7.35;
temperature >38 C; SpO2< 88% at rest with a fraction of
inspired oxygen 0.5; resting systolic blood pressure
<90 mmHg or >160 mmHg; resting diastolic blood pressure
<60 mmHg or >100 mmHg; unstable angina or a myocardial
infarct during the previous month; resting heart rate (HR)
>120 beats/min; or decreased level of consciousness.
Study design and protocol
A randomised crossover study with repeated measures was
performed on an ambulatory respiratory medicine ward of
a large teaching hospital with a dedicated acute NIV
service.
Participants were asked to perform two six minute walk
tests (6MWT) and two UAE tests. In those participants who
performed both 6MWT and UAE tests, the order of testing
was randomised. In addition, the order of 6MWT with O2
alone and with NIVþO2 was randomised, and the order of
UAE with O2 alone and with NIVþO2 was randomised. If a
participant was unable to perform both series of 6MWT and
UAE tests due to a musculoskeletal or neurological condi-
tion that affected the upper or lower limbs, the type of test
the participant was able to perform was selected. The
randomisation scheme was generated using a web site
(http://www.Randomization.com) and test order was con-
cealed in a sealed, opaque envelope until written consent
was obtained from participants. All tests were completed
within one day. Ethical approval was obtained from the
Human Ethics Committee of Sydney South West Area Health
Service and The University of Sydney. The study was
registered as part of a larger trial with the Australian New
Zealand Clinical Trials Registry (ACTRN12605000215628).
One hour prior to the two 6MWTs, a practice 6MWT was
conducted with NIVþO2 to familiarise participants to the
test20 and to walking with NIV. Similarly, one hour prior to the
two UAE tests, a practice UAE test was conducted with O2
alone to familiarise participants to the test. Participants
rested for at least one hour between each 6MWT and at least
one hour between each UAE test and until SpO2, HR, dyspnoea
and perceived exertion scores returned to baseline. Oxygen
flow was delivered to ensure a resting SpO2 of approximately
93% and was not adjusted further during exercise. Stand-
ardised encouragement was given each minute during exer-
cise. Participants were instructed to exercise until they felt
too breathless or fatigued to continue. The investigator
paused the 6MWTor stopped theUAE test if SpO2< 75% during
exercise. In addition, the UAE test was terminated if partici-
pants could not keep in time with the metronome.Exercise tests
Six minute walk test
The 6MWT was performed according to the American
Thoracic Society guidelines21 with two exceptions. Firstly,
participants used a forearm support frame to enable them
to walk safely and independently, and secondly, a research
assistant pushed a trolley containing the bilevel machine
and related equipment behind the participant during each
6MWT.
Table 1 Participant characteristics.
6MWT (nZ 18) UAE test (nZ 16)
Age yrs 65 (61e68) 64 (56e66)
F/M 10/8 8/8
BMI kg m2 27.2 8.3 27.6 8.0
Diagnostic group (n)
COPD 12 12
Bronchiectasis 2 2
Cystic fibrosis 1 1
Kypho/scoliosis 3 1
Domiciliary NIV (prior to admission) 4 5
Reason for acute on chronic HRF (n)
AECOPD 12 11
Respiratory tract infection 6 6
Pulmonary oedema 1 1
Hyperoxia 6 5
ABG on admission
pH 7.30 0.05 7.30 0.04
PaCO2 mmHg 73.8 15.3 71.6 15.0
PaO2 mmHg 68.5 (51.0e95.0) 76.5 (58.0e97.0)
HCO3
 mmol/L 32.0 (29.0e39.0) 32.8 5.3
SaO2% 94.0 (89.0e97.0) 92.3 (90.0e97.0)
Supp O2 (L/min) 2.7 2.1 2.0 (1.0e2.5)
NIV use 24 h prior to the study
Number of participants on NIV 18 16
Hours 10.9 5.1 11.0 4.6
ABG prior to exercise tests
pH 7.39 0.03 7.39 0.03
PaCO2 mmHg 58.6 9.1 57.9 8.9
PaO2 mmHg 70.3 17.8 72.9 17.5
HCO3
 mmol/L 34.0 5.8 33.9 5.0
SaO2% 92 5 93 4
Supp O2 (L/min) 3.0 (2.0e4.0) 2.0 (1.0e2.0)
Pulmonary function
FEV1% predicted 21 (16e27) 21 (16e24)
FVC% predicted 45 21 48 22
FEV1/FVC% 46 17 43 13
PImax1.0 cmH2O% predicted 54 28 65 27
NIV settings during exercise
IPAP cmH2O 15.5 (15.0e18.0) 15.8 1.6
EPAP cmH2O 5.0 (4.0e5.0) 5.0 (5.0e5.0)
PS (IPAPeEPAP) cmH2O 11.0 (10.0e13.0) 10.5 (10.0e12.0)
Data are presented as mean SD or median (interquartile range). 6MWT: six minute walk test; UAE: unsupported arm exercise; F/M:
female/male; BMI: body mass index; COPD: chronic obstructive pulmonary disease; NIV: non-invasive ventilation; AECOPD: acute
exacerbation of chronic obstructive pulmonary disease; ABG: arterial blood gas; PaCO2: arterial carbon dioxide tension; PaO2: arterial
oxygen tension; HCO3
: arterial bicarbonate ion concentration; SaO2: oxygen saturation; Supp O2: supplemental oxygen; FEV1: forced
expiratory volume in one second; FVC: forced vital capacity; PImax1.0: plateau maximal inspiratory mouth pressure; IPAP: inspiratory
positive airway pressure; EPAP: expiratory positive airway pressure; PS: pressure support. Note: participants occasionally had more than
one reason for admission to hospital.
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An externally paced unsupported arm exercise test as
described by Takahashi and colleagues22 was modified to
measure endurance rather than peak exercise capacity. The
test required the seated participant to lift a weighted dowel
fromwaist height to increasingly higher levels on a chart. The
pace of lifting was one lift every two seconds in time witha metronome. In a practice test, after five repetitions (10 s)
at each level, participants progressed through the levels on
the chart until they reached a level that they deemed to be
a moderate workload on the rate of perceived exertion (RPE)
scale (score of 3). Participants were instructed to exercise at
this level for as long as possible. The same level on the chart
that was achieved in the practice test was used for the two
subsequent UAE tests.
222 C. Menadue et al.Measures
Anthropometric data, an arterial blood gas, spirometry
(Microloop, Micromedical Limited, Rochester, Kent,
England) and maximum inspiratory occlusion mouth pres-
sures (Morgan Medical Limited, Gilingham, England) were
collected prior to testing. Participants then sat quietly for
ten minutes breathing supplemental O2 prior to O2 tests or
breathing with NIVþO2 prior to NIVþO2 tests before
baseline measures of SpO2, HR, dyspnoea and RPE (leg
muscle exertion for 6MWTs and arm muscle exertion for
UAE tests) were recorded. Oxygen saturation and HR were
recorded continuously during exercise using a pulse
oximeter (Radical, Massimo, Irvine CA, USA). Dyspnoea
and RPE23 were measured on a 0e10 category-ratio scale at
baseline, every 30 s during exercise, and at end exercise.
Blood pressure was measured manually at baseline and end
exercise.
Non-invasive ventilation
Non-invasive ventilation was delivered using a pressure
preset bilevel machine (VPAPIII ST, ResMed, Sydney,
Australia) via a full face mask (Ultra-mirage, ResMed,
Sydney, Australia; or, Comfort-Full, Respironics, Murrys-
ville, PA, USA). The bilevel machine was set in the spon-
taneous mode with an expiratory positive airway pressure
(EPAP) of 4e5 cmH2O. Inspiratory positive airway pressure
(IPAP) was set 10 cmH2O above EPAP and was increased at
rest to a level of comfort. Exercise settings are described in
Table 1. The inspiratory trigger threshold was 4.5 L/min and
maximum inspiratory flow rate was 170 L/min. The
minimum rise time (time from EPAP to IPAP) of 100 ms was
used. Supplemental O2 was added via a t-piece near the air
outlet of the machine. A 12-volt external battery powered
the bilevel machine during walking.
Data analysis and statistics
The primary outcome measure for the 6MWT was total
distance walked. Secondary outcome measures were
distance and time to first rest, isotime SpO2 and dyspnoea.
Isotime was defined as the earliest time-point where the
participant rested during either 6MWT. Dyspnoea scores
and SpO2 from NIVþO2 and O2 tests were compared at this
point in time. To detect a 48 metre change in 6MWD24 with
NIVþ O2, using a SD estimate of 51 m (based on data from
the first 5 participants), power of 0.8, and a of 0.05,
a sample of 18 participants was required. For UAE, the
primary outcome measure was endurance time and
secondary outcome measures were isotime SpO2 and
dyspnoea, where isotime was defined as the end point of
the shorter endurance test. To detect a 30 s change in UAE
endurance time with NIVþ O2, using a SD estimate of 39 s
(based on data from the first 5 participants), power of 0.8,
and a of 0.05, a sample of 16 participants was needed.
Descriptive data for continuous variables with a normal
distribution are presented as mean standard deviation
(SD), or median and interquartile range (IQR) for data that
failed the Kolmogorob-Smirnov normality test. Paired
t-tests, or Wilcoxon signed rank tests for non-parametricdata, were conducted to determine if there was a differ-
ence between exercise with NIVþO2 and exercise with O2
alone with respect to the primary and secondary outcome
measures. A significance level of p< 0.05 was used for all
comparisons.
Results
The median time from hospital admission to performance of
the exercise tests was 4 days (IQR 2e7). All participants
completed the exercise tests. Oxygen saturation fell below
75% in three participants during the 6MWT with O2. No
adverse events occurred.
Six minute walk test
Exercise with NIVþO2 significantly increased total distance
walked by a mean 43.4 m (95% CI 14.1e72.8, pZ 0.006)
compared to exercise with O2 alone (Table 2, Fig. 1a). In
addition, distance to first rest, time to first rest and isotime
SpO2 were increased, while isotime dyspnoea was
decreased with NIVþO2 during walking (Table 2, Fig. 1b).
The primary symptom limiting walking was dyspnoea
(NIVþO2: nZ 14; O2 alone: nZ 17), leg muscle fatigue
(NIVþO2: nZ 2; O2 alone: nZ 0), or a combination of
dyspnoea and leg muscle fatigue (NIVþO2: nZ 2; O2 alone:
nZ 1). There was no effect of test order on any of the
primary or secondary outcome measures.
Unsupported arm exercise
There was a statistically significant increase in UAE endur-
ance time with NIVþ O2 compared to exercise with O2
alone [median 201 s (IQR 93e414) versus 157 s (90e342),
pZ 0.033] (Table 3, Fig. 2a). There was no difference in
isotime SpO2 or dyspnoea with NIVþO2. However, isotime
RPE was reduced compared to exercise with O2 alone (Table
3, Fig. 2b). The primary symptom limiting UAE was arm
muscle fatigue (NIVþO2: nZ 15; O2 alone: nZ 14), dysp-
noea (NIVþ O2: nZ 1; O2 alone: nZ 1), or a combination of
arm muscle fatigue and dyspnoea (O2 alone: nZ 1). There
was no effect of test order on any of the primary or
secondary outcome measures.Discussion
The main findings of the present study were that bilevel
NIVþO2 during ground walking increased distance walked,
improved SpO2 and reduced dyspnoea compared to exercise
with O2 alone in patients recovering from acute on chronic
HRF. An improvement in UAE endurance time was also
found with NIVþ O2 compared to exercise with O2 alone,
and was associated with a reduction in arm muscle fatigue.
Exercise performed several days after admission to hospital
was safe and well tolerated in these patients.
Improvements in exercise capacity and dyspnoea have
been observed after exercise training in patients recovering
from acute respiratory failure.8,25 However, severe dysp-
noea8 and unstable gas exchange can delay activity and
place patients at risk of further deconditioning in the early
Table 2 Six minute walk test with oxygen (O2) alone compared with non-invasive ventilation plus oxygen (NIVþO2).
O2 NIVþO2 Mean difference (95% CI) p
Rest
SpO2 (%) 93 (92e96) 95 (93e98) FN <0.000
Supp O2 (L/min) 1.5 (0.5e3.0) 1.5 (0.5e3.0) FN 0.75
HR (beats/min) 90 14 91 17 1 (3 to 4) 0.61
Dyspnoea (Borg) 0.5 (0e0.8) 0.3 (0e0.8) FN 0.32
RPE (Borg) 0 (0e0.5) 0 (0e0.5) FN 0.28
SBP (mmHg) 125.0 17.7 123.6 14.1 1.4 (8.6 to 5.7) 0.68
DBP (mmHg) 73.0 13.0 77.5 7.0 4.5 (1.7 to 10.7) 0.14
MAP (mmHg) 90.3 12.0 92.8 8.9 2.5 (2.7 to 7.6) 0.32
Isotime
SpO2 (%) 87 6 92 5 5 (2 to 7) 0.001
HR (beats/min) 109 14 108 15 2 (4 to 1) 0.15
Dyspnoea (Borg) 4.0 (3.0e5.0) 2.0 (1.0e4.0) FN 0.028
RPE (Borg) 3.0 (2.0e5.0) 3.0 (1.0e3.0) FN 0.46
End exercise
SpO2 (%) 89 7 90 6 2 (2 to 6) 0.26
HR (beats/min) 109 14 108 20 1 (8 to 6) 0.72
Dyspnoea (Borg) 4.9 2.9 5.4 3.0 0.4 (0.6 to 1.5) 0.37
RPE (Borg) 4.4 3.1 4.9 3.0 0.8 (0.8 to 1.8) 0.41
SBP (mmHg) 140.2 17.4 140.1 15.6 0.7 (5.5 to 4.1) 0.76
DBP (mmHg) 80.2 11.9 83.5 9.6 3.1 (0.5 to 6.7) 0.086
MAP (mmHg) 100.2 12.9 102.4 11.0 1.8 (1.4 to 5.0) 0.24
Total distance (m) 187.5 89.9 230.9 114.8 43.4 (14.1 to 72.8) 0.006
Distance to 1st rest (m) 159.8 97.1 221.4 119.8 61.6 (19.6 to 103.6) 0.007
Time to 1st rest (s) 188 (151e360) 360 (284e360) FN 0.012
Data are presented as mean SD or median (interquartile range). O2: oxygen; NIVþO2: non-invasive ventilation plus oxygen; SpO2:
oxygen saturation; Supp O2: supplemental oxygen; HR: heart rate; RPE: rate of perceived exertion; SBP: systolic blood pressure; DBP:
diastolic blood pressure; MAP: mean arterial pressure; FN: failed normality test.
NIV during exercise in acute respiratory failure 223stages of recovery. The detrimental effects of prolonged
bed rest on muscle strength and function are well
described.26 Currently, there are no evidence-based
recommendations regarding strategies to alleviate dysp-
noea and improve functional exercise performance in the
early stages of recovery from acute on chronic HRF. The
present study provides novel information in this area.
Effect of non-invasive ventilation plus oxygen
during ground walking
The present study is the first to demonstrate the benefits of
NIV during walking in patients recovering from acute on
chronic HRF. Total distance walked increased by a mean of
43.4 m, and distance to first rest increased by a mean of
61.6 m with NIVþ O2 compared to walking with O2 alone.
The minimal clinically important difference in 6MWD is not
known in patients recovering from acute on chronic HRF.
However, the change in 6MWD with NIVþ O2 is comparable
to the mean change in 6MWD of 48 m (95% CI 32e65) after
at least four weeks of supervised outpatient pulmonary
rehabilitation in patients with COPD.24 Median time to
‘‘first rest’’ was 6 min with NIVþO2 compared to 3.1 min
with O2 alone, indicating that many participants completed
the 6MWTwith NIVþ O2 without stopping to rest. While it is
unknown whether the changes observed are clinically
significant, the reduction in dyspnoea and improvement in
oxygenation observed suggest that NIVþ O2 during walkingmay allow patients to commence exercise earlier in the
recovery phase, thus reducing the risk of deconditioning.
The mechanisms of improved walking performance with
NIVþ O2 most likely relate to the reduction in dyspnoea and
improvement in SpO2 compared to walking with O2 alone
that was observed at isotime exercise. As dyspnoea was the
primary symptom that limited walking in our participants,
reduction of this unpleasant symptom with NIVþO2 prob-
ably played a key role in allowing participants to walk
further with fewer rests. In stable patients with COPD,
NIV during exercise was found to reduce dyspnoea in
proportion to respiratory muscle unloading.9,10 Similarly in
patients recovering from acute on chronic HRF, NIV may
have unloaded the respiratory muscles, thereby reducing
dyspnoea.
Oxygen saturation was higher with NIVþO2 during exer-
cise and this may have resulted in improved muscle
oxygenation and contributed to the improvement in exercise
performance.27 In addition, patients with chronic HRF due to
severe COPD or kyphoscoliosis can develop a combined
respiratory and metabolic acidosis during exercise.12,13
Acute hypercapnia with a respiratory acidosis can signifi-
cantly impair respiratory muscle function.28,29 In stable
patients, NIV during exercise has been shown to reduce
exercise induced hypercapnia and improve exercise perfor-
mance.12,13 However, the advantage of NIVþ O2 during
walking over O2 alone in preventing CO2 retention in patients
recovering from acute on chronic HRF is yet to be confirmed.
Figure 1 (a) Total distance walked during the six minute walk test with oxygen alone (O2) compared with non-invasive ventilation
plus oxygen (NIVþO2). Whiskers represent standard deviation; (b) Isotime dyspnoea during the six minute walk test with oxygen
alone (O2) compared with non-invasive ventilation plus oxygen (NIVþO2). Whiskers represent interquartile range. Closed circles
represent data from participants with chronic obstructive lung disease; open squares represent data from participants with
restrictive chest wall disorders; *p< 0.05; yp< 0.01.
224 C. Menadue et al.Finally, EPAP may have assisted participants with severe
airflow limitation and intrinsic positive end expiratory
pressure (PEEP) during walking. Dynamic hyperinflation
commonly occurs during ground walking in patients with
severe COPD and is associated with an increase in dyspnoea
in proportion to the reduction in inspiratory capacity.30
Application of external PEEP at rest has been shown to
unload the respiratory muscles in patients with COPD and
acute HRF with intrinsic PEEP.31 Whether the application of
EPAP during exercise can delay the onset or extent of
dynamic hyperinflation remains to be demonstrated inTable 3 Unsupported arm exercise with oxygen (O2) alone com
O2 NIVþO
Rest
SpO2 (%) 93 2 94 2
Supp O2 (L/min) 2.0 (1.0e3.0) 1.0 (1.0
HR (beats/min) 91 14 92 16
Dyspnoea (Borg) 0.8 (0e1.0) 0.8 (0e
RPE (Borg) 0 (0e1.0) 0 (0e0.
SBP (mmHg) 122.3 15.2 120.8
DBP (mmHg) 77.8 10.7 77.8 1
MAP (mmHg) 92.7 11.6 92.1 1
Isotime
SpO2 (%) 92 3 93 3
HR (beats/min) 100 14 98 19
Dyspnoea (Borg) 4.9 3.1 4.0 2.
RPE (Borg) 6.6 3.0 5.6 3.
End exercise
SpO2 (%) 92 2 93 3
HR (beats/min) 101 16 102 16
Dyspnoea (Borg) 5.1 3.0 5.0 2.
RPE (Borg) 6.9 2.8 6.7 2.
SBP (mmHg) 139.4 18.6 134.7
DBP (mmHg) 84.5 10.9 81.8 9
MAP (mmHg) 102.8 12.3 99.4 1
Endurance time (s) 157 (90e342) 201 (93
Data are presented as mean SD or median (interquartile range). Repatients recovering from acute on chronic HRF as well as in
those with stable COPD.
Effect of non-invasive ventilation plus oxygen during
unsupported arm exercise
While a statistically significant improvement in UAE
endurance time was found with NIVþO2 compared to
exercise with O2 alone, examination of individual data
(Fig. 2) revealed that only a few participants demonstrated
a substantial increase in endurance time. This is in contrast
to a previous study performed by our group in patients withpared with non-invasive ventilation plus oxygen (NIVþO2).
2 Mean difference (95% CI) p
1 (0 to 2) 0.087
e3.0) FN 0.068
1 (2 to 4) 0.57
1.0) FN 0.92
5) FN 1.0
15.7 1.5 (5.9 to 2.9) 0.48
0.3 0.1 (2.9 to 2.8) 0.96
1.5 0.6 (3.3 to 2.2) 0.68
1 (1 to 3) 0.21
2 (6 to 2) 0.26
7 1.0 (2.2 to 0.3) 0.11
1 1.0 (1.9 to 0.1) 0.037
1 (1 to 3) 0.20
1 (1 to 3) 0.29
8 0.2 (1.6 to 1.3) 0.82
9 0.3 (1.1 to 0.6) 0.53
18.5 4.7 (9.5 to 0.1) 0.054
.8 2.7 (5.7 to 0.3) 0.074
1.9 3.3 (6.3 to 0.4) 0.031
e414) FN 0.033
fer to Table 2 for abbreviations.
Figure 2 (a) Unsupported arm exercise endurance time with oxygen alone (O2) compared with non-invasive ventilation plus
oxygen (NIVþO2). Whiskers represent interquartile range; (b) Isotime rate of perceived exertion during the unsupported arm
exercise test with oxygen alone (O2) compared with non-invasive ventilation plus oxygen (NIVþO2). Closed circles represent data
from participants with chronic obstructive lung disease; open squares represent data from participants with restrictive chest wall
disorders; *p< 0.05.
NIV during exercise in acute respiratory failure 225stable chronic HFR, where NIV increased UAE endurance
time by a mean of 91 s compared to exercise without NIV.16
Pressure support during exercise has previously been shown
to improve SAE capacity in people recovering from acute on
chronic HRF who were slow to wean from mechanical
ventilation.19 Due to specificity of training, UAE is prefer-
able over SAE for functional exercise training.32 However,
UAE is more difficult to perform than SAE because during
UAE, some accessory respiratory muscles have a dual task
of performing the upper limb activity as well as assisting
respiration. Consequently, some of the ventilatory load is
shifted to the diaphragm and abdominal muscles.33
In our participants, despite arm muscle fatigue being the
primary symptom that limited UAE, severe dyspnoea (mean
4.9) was reported at isotime during exercise with O2 alone.
Non-invasive ventilation has previously been shown to
unload the diaphragm during arm elevation in patients with
chronic HRF.34 The inverse relationship between respiratory
muscle unloading and dyspnoea9 has been discussed previ-
ously. We found a small non-significant reduction in isotime
dyspnoea (mean 1.0) with NIVþ O2 compared to UAE with
O2 alone. This was considerably lower than the mean
reduction in isotime dyspnoea of 2.3 that was found with
NIV during UAE in stable patients with chronic HRF.16 It is
possible that the level of pressure support (IPAPeEPAP)
delivered in the current study was too low to sufficiently
unload the respiratory muscles during UAE in the majority
of participants, and therefore to significantly reduce
dyspnoea and cause a substantial increase in exercise
endurance time.
In the present study, isotime RPE (arm muscle fatigue)
was reduced by a mean of 1.0 on the Borg scale with
NIVþ O2 during UAE which was similar to the reduction in
isotime RPE observed in stable patients with chronic HRF.16
Despite this reduction, the majority of participants even-
tually terminated UAE due to arm muscle fatigue whether
NIVþ O2 or O2 alone was used. The fatigue was most likely
attributable to the effect of repetitive exercise in a small
muscle group. However, even a small reduction of arm
muscle fatigue may enable patients recovering from acuteon chronic HRF to better tolerate UAE early in the recovery
period.
The use of NIVþ O2 during exercise as part of routine
clinical practice does have resource implications. There-
fore, investigation of the cost-benefit relationship of such
a strategy during early exercise rehabilitation in people
recovering from acute on chronic HRF is warranted and
should evaluate outcome measures including staff time,
length of stay, functional exercise capacity, physical
activity and quality of life following discharge.
Limitations
Neither participants nor investigators were blinded to NIV
in this study. To minimise potential bias, standardised
instructions and encouragement were given. Sham NIV was
not used because an effective sham has not been identified
for this population. In addition, we had to limit the number
of tests performed to prevent excessive fatigue, and wan-
ted to compare the effect of NIVþ O2 during exercise to
usual clinical practice (exercise with O2 alone) rather than
sham.
Another potential limitation was that a heterogeneous
group of patients were studied. While the mechanisms that
contribute to dyspnoea and exercise limitation differ
between patients with severe chronic lung disease and
those with severe chest wall restriction, both groups often
have very limited ventilatory reserve during exercise,4,5
both have been shown to derive benefit from NIV during
exercise when stable,3,11,14,16 and examination of indi-
vidual data (Figs. 1 and 2) does not suggest a particular
pattern of response to NIV during exercise based on diag-
nostic group alone. In addition, disease severity appears to
be an important factor that affects the response to NIV
during exercise, even within patients from the same diag-
nostic group. This has been demonstrated in people with
stable COPD,3,35 kyphoscoliosis14 and with CPAP during
exercise in people with cystic fibrosis,36 where those
subjects with more severe disease achieved greater
improvements with NIV or CPAP during exercise than those
with less severe disease. The participants included in the
226 C. Menadue et al.present study all had severe disease with a greatly reduced
ventilatory capacity, and therefore presented as a group
who may benefit from NIVþO2 during exercise.
Conclusion
Bilevel NIVþO2 during ground walking resulted in an
immediate improvement in distance walked and SpO2
compared to exercise with O2 alone in people recovering
from acute on chronic HRF. The combination of NIVþO2
reduced dyspnoea during walking and arm muscle fatigue
during UAE compared to exercise with O2 alone and
therefore may assist patients to tolerate exercise rehabil-
itation early in the recovery phase in an attempt to avoid
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